
Sexual and Reproductive health care
Sexual and reproductive health services provide confidential, inclusive, and evidence-based care to support physical, emotional, and social wellbeing across the lifespan.
A broad range of services are available for individuals experiencing sexual and reproductive health concerns, including issues with desire/libido, arousal, orgasm, painful sex, menstrual problems (PMS, PMDD, dysmenorrhea), chest/breast problems, endometriosis, fibroids, pelvic pain, PCOS, vaginitis, bacterial vaginosis, urinary tract infection, yeast infection, infertility, and related conditions.
​
Comprehensive care includes:
-
Assessment and diagnosis: A thorough history, physical exam, and use of validated tools (e.g., Female Sexual Function Index, Female Sexual Distress Scale-Revised) help identify the nature and impact of sexual dysfunction, menstrual disorders, and pelvic pain.
-
Psychological and behavioral interventions: Cognitive behavioral therapy (CBT), mindfulness-based therapy, and sex therapy are first-line for desire, arousal, and orgasmic disorders, and are effective for distressing sexual symptoms.
-
Medical management:
-
For low desire, FDA-approved options for premenopausal women include flibanserin and bremelanotide; off-label testosterone may be considered for postmenopausal women.
-
Genito-pelvic pain (e.g., dyspareunia, vaginismus) may be managed with vaginal lubricants, topical estrogen, ospemifene, pelvic floor physical therapy, and, when indicated, treatment of underlying gynecologic conditions (e.g., endometriosis, fibroids).
-
Menstrual disorders, PCOS, endometriosis, and fibroids are managed with hormonal therapies, pain management, and surgical options as needed.
-
Infections (UTI, vaginitis, BV, yeast) are treated with appropriate antimicrobials.
-
Infertility evaluation and management include hormonal assessment, imaging, and referral to reproductive endocrinology as appropriate.
-
-
Education and counseling: Patient-centered communication, education about sexual health, and support for relationship and psychosocial factors are integral.
-
Referral and multidisciplinary care: Complex cases may require referral to specialists in gynecology, urology, pelvic pain, reproductive endocrinology, or mental health.
To illustrate the multidimensional assessment required for sexual dysfunction, the following table summarizes key factors to consider:
A comprehensive, biopsychosocial approach ensures that care is tailored to each individual's needs and goals.

Sexual and Reproductive Health Concerns
Sexually transmitted infections (STIs) can be acquired through oral, anal, or vaginal sex, as well as through genital skin-to-skin contact. Many STIs are asymptomatic, so regular testing is the only reliable way to confirm infection and prevent complications.
​
Testing recommendations:
-
Chlamydia and gonorrhea: Annual screening is recommended for all sexually active women under 25 and older women with risk factors, and for men who have sex with men (MSM) at least annually, with more frequent testing (every 3–6 months) for higher-risk individuals. Testing should include all sites of exposure (urine/genital, rectal, pharyngeal).
-
Syphilis: Screen MSM, pregnant individuals, and others at increased risk at least annually; diagnosis is by serology (nontreponemal and treponemal tests).
-
HIV: At least once for all adults and adolescents, with annual or more frequent testing for those at higher risk.
-
Trichomoniasis: Annual screening for women with a vagina/neovagina who are at risk; not routinely recommended for asymptomatic men.
-
HPV: Pap/HPV testing for cervical cancer screening per guidelines; no routine screening for other sites.
-
Hepatitis B: Screen all adults at least once, with vaccination for those not immune.
-
Genital warts (HPV): Diagnosis is clinical; no routine screening.
Treatment: Most bacterial STIs (chlamydia, gonorrhea, syphilis, trichomoniasis) are curable with antibiotics, but antimicrobial resistance is a concern for gonorrhea. Viral STIs (HSV, HPV, hepatitis B, HIV) are managed with antiviral therapy or supportive care; only hepatitis B and HIV have effective preventive vaccines or pre-exposure prophylaxis (PrEP).
Prevention and follow-up: Consistent condom use, vaccination (HPV, hepatitis B), and PrEP for HIV reduce risk. All sexual partners should be notified, tested, and treated as appropriate.
Summary: Because most STIs are asymptomatic, routine, site-specific screening and prompt treatment are essential for sexually active individuals. Testing should be tailored to sexual practices and risk factors, and prevention counseling should be part of every sexual health visit.
Pain with intercourse is a common complaint for women of all ages.
Research now shows that the majority of dyspareunia is caused by physical conditions that plays a large psychological influence on sexual health.
Dyspareunia, itself is not merely a disease but rather a symptom with many different causes.
Together, you and your sexual health care team will work collaboratively to develop an individual treatment plan to optimize your sexual health.
